Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.074 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.06 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |